Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.21 USD
−8.57 M USD
1.00 M USD
46.48 M
About MediciNova, Inc.
Sector
CEO
Yuichi Iwaki
Headquarters
La Jolla
Website
Founded
2000
FIGI
BBG000RDP030
MediciNova, Inc. is a biopharmaceutical company, which engages in the acquisition and development of small molecule therapeutics for the treatment of diseases with unmet medical needs. The company was founded by Yuichi Iwaki on September 26, 2000, and is headquartered in La Jolla, CA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MNOV is 2.13 USD — it has increased by 6.50% in the past 24 hours. Watch MediciNova, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange MediciNova, Inc. stocks are traded under the ticker MNOV.
MNOV stock has risen by 12.11% compared to the previous week, the month change is a 23.84% rise, over the last year MediciNova, Inc. has showed a 17.03% increase.
We've gathered analysts' opinions on MediciNova, Inc. future price: according to them, MNOV price has a max estimate of 10.00 USD and a min estimate of 10.00 USD. Watch MNOV chart and read a more detailed MediciNova, Inc. stock forecast: see what analysts think of MediciNova, Inc. and suggest that you do with its stocks.
MNOV reached its all-time high on Dec 13, 2006 with the price of 16.12 USD, and its all-time low was 1.12 USD and was reached on Aug 12, 2024. View more price dynamics on MNOV chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MNOV stock is 10.36% volatile and has beta coefficient of −1.77. Track MediciNova, Inc. stock price on the chart and check out the list of the most volatile stocks — is MediciNova, Inc. there?
Today MediciNova, Inc. has the market capitalization of 104.47 M, it has increased by 9.29% over the last week.
Yes, you can track MediciNova, Inc. financials in yearly and quarterly reports right on TradingView.
MediciNova, Inc. is going to release the next earnings report on Feb 14, 2025. Keep track of upcoming events with our Earnings Calendar.
MNOV earnings for the last quarter are −0.06 USD per share, whereas the estimation was −0.06 USD resulting in a 0.00% surprise. The estimated earnings for the next quarter are −0.06 USD per share. See more details about MediciNova, Inc. earnings.
MediciNova, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
MNOV net income for the last quarter is −2.85 M USD, while the quarter before that showed −2.63 M USD of net income which accounts for −8.52% change. Track more MediciNova, Inc. financial stats to get the full picture.
No, MNOV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 25, 2024, the company has 13.00 employees. See our rating of the largest employees — is MediciNova, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MediciNova, Inc. EBITDA is −11.96 M USD, and current EBITDA margin is −988.00%. See more stats in MediciNova, Inc. financial statements.
Like other stocks, MNOV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MediciNova, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MediciNova, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MediciNova, Inc. stock shows the neutral signal. See more of MediciNova, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.